BRUSSELS — Johnson & Johnson’s single-jab vaccine against Covid-19 will be limited in Belgium to people aged 41 and over, authorities said on Wednesday following the death of a woman who received the jab.
The country’s inter-ministerial health body focused on the pandemic said that restriction will be “provisionally” applied pending further guidance from the European Medicines Agency (EMA) on Johnson & Johnson’s Janssen vaccine.
The move underlined the level of caution EU countries are showing to Covid vaccines, particularly the two adenovirus ones made by Johnson & Johnson and by AstraZeneca.
Those two have suspected links to very rare but very serious instanc…
Keep on reading: Belgium limits J&J vaccine to over-41s after recipient’s death